Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jinmaitong
- Development stage
- Unknown
- Lead developer
- Peking Union Medical College Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jinmaitong (JMT) is a Traditional Chinese Medicine (TCM) formula developed by the Peking Union Medical College Hospital for the treatment of diabetic peripheral neuropathy (DPN). It is typically administered as a capsule or granule and is composed of several herbal ingredients, including *Astragalus membranaceus*, *Salvia miltiorrhiza*, *Scrophularia ningpoensis*, and *Paeonia lactiflora*. The formula is designed to improve nerve conduction velocity, alleviate neuropathic pain, and promote nerve repair and regeneration. Its mechanism of action involves reducing oxidative stress, inhibiting the formation of advanced glycation end-products (AGEs), and improving microcirculation in the peripheral nerves. Clinical studies have demonstrated its potential to enhance peripheral nerve blood flow and support the structural integrity of nerve fibers in diabetic patients.
- Brand names
- Jinmaitong
- Other names
- Jinmaitong capsuleJinmaitong granule
02
Targets
Thioredoxin-interacting protein/NLR family pyrin domain containing 3 inflammasome complexAR (Adrenergic receptors)
Beyond the preview
Go deeper on jinmaitong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jinmaitong.